3.2. Overall survival
The mean survival for the entire cohort was 12.88 ± 14.14 months,
spanning from 0 days to 85.37 months. Furthermore, the estimated
one-year survival rate for all patients was 45% (Figure
2). A notable disparity was observed upon gender-based analysis, with
women demonstrating a more favorable one-year survival rate of 60%
compared to men at 40%. Additionally, women exhibited significantly
longer mean survival time, with an average of 16.14 ± 17.35 months,
while men had a mean survival time of 10.75 ± 11.15 months (p = 0.023).
Individuals over 60 experienced shorter mean survival times than their
younger counterparts, with averages of 7.48 ± 7.06 months vs 15.9 ±
16.21 months, respectively. The age-dependent survival difference was
highly statistically significant (p < 0.001). Moreover,
patients aged 60 or younger demonstrated a significantly higher one-year
survival rate compared to their older counterparts (75% vs. 35%)